News

It’s no surprise that putting together a successful launch strategy for an oncology product is a complex process. And we’ve heard from many of our emerging pharma clients that it’s intimidating to see how saturated and competitive the landscape is. To cut through the noise and deliver a message that resonates with healthcare providers, payers, and patients, it’s important to recognize that strategic and integrated medical communications should be [...]

In a market where most medical affairs and medical communications service providers are built to support large pharma, Two Labs is aiming to fill the gap for small and emerging biopharma and biotech manufacturers with the launch of Medical Affairs & Communications. Read more here.

The main question that sits at the center of the most common licensing questions and obstacles for cell and gene strategies: how do companies license a product that is often never touched by the parties that need to hold the license? Ryan Fields, Sr. Vice President of Regulatory Services at Two Labs answers this question and more in his article featured on Pharmaceutical Outsourcing. Read more here.

The partnership expands Two Labs’ suite of services and broadens its integration competency to include government price reporting COLUMBUS, Ohio (7/7/2021) -- Two Labs, an industry-leading pharma services company and part of Envision Pharma Group, today announced that it has acquired Riparian, a pharma consulting and SaaS company that helps manufacturers navigate pricing regulations, reporting, strategies, and program operations. The acquisition expands Two Labs’ suite of pharma services, allowing the [...]

Oncology and other specialty therapies continue to get more and more expensive for payers, placing immense financial pressure on the HCP. The percentage increase in worldwide spending on oncology medications went up by double digits every year between 2013 and 2018, and reached nearly $150 billion in 2018. Modern cancer therapies significantly improve disease outlook, but with a tremendous cost of treatment. Read more from Two Lab’s Senior Consultant Anne [...]

With the new offering, Envision and Two Labs are poised to deliver more options and innovation to the Medical Science Liaison (MSL) Space. Two Labs Pharma Services and its parent company Envision Pharma Group – organizations that are deeply engaged in providing Medical Affairs services to biopharmaceutical companies – are proud to announce an exciting new, combined offering: MSL Solutions. Designed to grow and enhance both organizations’ ability to deliver [...]